<p>Dr Thomas Seck from Boehringer Ingelheim Pharmaceuticals discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.</p>
She answers our questions about her team's latest study on women who are training in cardiology, how women are represented in cardiology and its subspecialties, and more.
In this podcast, Anne Rose, PharmD, talks about factors associated with increased risk of recurrent VTE, appropriate duration of anticoagulation for VTE depending on risk/benefit analysis,...
<p>President and CEO of West Health, Shelley Lyford, discusses senior-specific models of care and&nbsp;the overall results of the "Survey on Aging in America."</p>
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine...
